The Molecular Diagnostics Market is projected to reach $25.59 billion by 2029, at a CAGR of 9.8% from 2022 to 2029. The molecular diagnostics market comprises advanced products and technologies used by medical professionals for patient management, from diagnosis to treatment, primarily focusing on areas such as infectious disease and cancer.
The growth of this market is driven by factors such as technological advancements in molecular diagnostics, the increasing use of PoC diagnostic tests, an increase in funding for the R&D of diagnostic products, the rising geriatric population, and the increasing prevalence of target diseases. However, unfavorable regulatory framework and cost of molecular diagnostic tests hamper the growth of this market to a notable extent.
Impact of COVID-19 on the Molecular Diagnostics Market
The COVID-19 pandemic had a positive impact on the molecular diagnostics market in terms of revenue. However, the diagnosis of other disorders was reduced during the initial phase of the pandemic, and the COVID-19 testing capabilities were increased to limit the spread of infection. Some of the initiatives are mentioned below:
Such initiatives positively impacted the demand for molecular diagnostics for COVID-19 during the pandemic.
Click here to: Get Free Sample Copy of this report
Increase in Funding for R&D
The development of molecular diagnostic systems or assays requires significant capital investments. Thus, financial support in the form of funding is essential to develop and bring the technology into the market. There are many molecular diagnostic devices in the developmental phase that are being funded by various organizations. Below are some examples related to funding received by the companies that helped them focus on developing molecular diagnostics products.
Key Findings of the Molecular diagnostics Market Study
In 2022, the Reagents & Kits Segment is Expected to Dominate the Molecular Diagnostics Market
Based on product, in 2022, the reagents & kits segment is expected to account for the largest share of the molecular diagnostics market. Recurrent use of assays & kits in the detection of various diseases through molecular diagnostics, rise in product approvals, and technological advancements in molecular techniques contribute to the large market share of this segment.
In 2022, the Lab Tests Segment is Expected to Dominate the Molecular Diagnostics Market
Based on test type, in 2022, the lab tests segment is expected to account for the largest share of the molecular diagnostics market. Lab tests are traditionally used in hospitals and diagnostic centers and are widely accepted. These factors contribute to the large market share of this segment.
In 2022, the Polymerase Chain Reaction (PCR) Segment is Expected to Dominate the Molecular Diagnostics Market
Based on technology, in 2022, the polymerase chain reaction (PCR) segment is expected to account for the largest share of the molecular diagnostics market. The specificity and sensitivity of the instrument and the technological developments in various diagnostic applications contribute to this segment's large market share.
In 2022, the Infectious Diseases Segment is Expected to Dominate Molecular Diagnostics Market
Based on application, in 2022, the infectious diseases segment is expected to account for the largest share of the molecular diagnostics market. Infectious diseases are transmissible or communicable illnesses that spread quickly in some areas and become epidemics. It is crucial to quickly diagnose initial infections and prevent further spread through in vitro diagnosis. The growing prevalence of infectious diseases, the rising funds for infectious disease diagnostic research activities, and the sudden emergence of a pandemic are the factors attributed to the large market share of this segment.
In 2022, the Hospitals & Clinics Segment is Expected to Dominate Molecular Diagnostics Market
Based on end user, in 2022, the hospitals & clinics segment is expected to account for the largest share of the molecular diagnostics market. Factors attributing to this segment's share include increased hospitalizations due to various diseases, the rise in the geriatric population, and the high prevalence of healthcare-associated infections (HAIs).
Asia-Pacific: Fastest-growing Regional Market
Based on geography, Asia-Pacific is slated to record the fastest growth rate during the forecast period. The growth of this regional market is mainly driven by the rising prevalence of infectious & chronic diseases, the increasing number of hospitals and diagnostic laboratories, efforts to improve the accessibility of diagnostic services, and the growing demand for clinical testing.
Key Players
The key players profiled in the molecular diagnostics market study are F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (U.S.), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (BD) (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Illumina, Inc. (U.S.).
Scope of the Report:
Molecular Diagnostics Market, by Product
Molecular Diagnostics Market, by Test Type
Molecular Diagnostics Market, by Technology
Molecular Diagnostics Market, by Application
Molecular Diagnostics Market, by End User
Molecular Diagnostics Market, by Geography
Key questions answered in the report:
The molecular diagnostics market study covers the market sizes & forecasts for various molecular diagnostics products used in the healthcare sector. The report involves the value analysis of various segments and subsegments of the molecular diagnostics market at the regional and country levels.
The molecular diagnostics market is projected to reach $25.59 billion by 2029, at a CAGR of 9.8% during the forecast period.
In 2022, the reagents/kits segment is expected to account for the largest share of the molecular diagnostics market. This segment is also projected to register the highest CAGR during the forecast period. The fast growth rate of this segment is driven by the need for kits for the growing prevalence of diseases and the growing awareness of early diagnosis among the people.
The diagnostic laboratories segment is slated to register the highest CAGR during the forecast period. The growth of this segment is driven by the expansion of diagnostic laboratories and the installation of advanced systems in laboratories.
The growth of this market is driven by factors such as technological advancements in molecular diagnostics, increasing use of PoC diagnostic tests, an increase in focus and funding for R&D of diagnostic products, and rising geriatric population and increasing prevalence of target diseases.
In addition, growth opportunities in emerging countries and companion diagnostics offering new growth potential are expected to provide significant opportunities for the growth of this market.
The key players operating in the molecular diagnostics market are F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (U.S.), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (BD) (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Illumina, Inc. (U.S.).
Emerging economies from Asia-Pacific, such as China and India, are projected to offer significant growth opportunities for vendors operating in this market due to the growing awareness about infectious diseases, focus on technological advancements, increasing geriatric population, and increasing investment in the healthcare sector.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Technological Advancements in Molecular Diagnostics
4.2.2. Increasing use of PoC Diagnostic Tests
4.2.3. Increase in Focus and Funding for R&D of Diagnostic Products
4.2.4. Rising Geriatric Population
4.2.5. Rising Prevalence of Communicable and Non-communicable Diseases
4.3. Restraints
4.3.1. Unfavorable Regulatory Framework
4.3.2. High Cost of Molecular Diagnostic Tests
4.4. Opportunities
4.4.1. Emerging Economies
4.4.2. Companion Diagnostics to Offer New Growth Potential
4.5. Challenges
4.5.1. Dearth of Skilled Professionals
4.6. The Impact of COVID-19 on the Global Molecular Diagnostics Market
5. Molecular Diagnostics Market, by Product
5.1. Introduction
5.2. Reagents & Kits
5.3. Instruments/Systems
5.4. Software & Services
6. Molecular Diagnostics Market, by Test Type
6.1. Introduction
6.2. Lab Tests
6.3. PoC Tests
7. Molecular Diagnostics Market, by Technology
7.1. Introduction
7.2. Polymerase Chain Reaction (PCR)
7.3. In Situ Hybridization (ISH)
7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5. Chips and Microarray
7.6. Mass Spectrometry
7.7. Sequencing
7.8. Transcription Mediated Amplification (TMA)
7.9. Other Technologies
8. Molecular Diagnostics Market, by Application
8.1. Introduction
8.2. Infectious Diseases
8.2.1. Hepatitis
8.2.2. HIV
8.2.3. Healthcare-associated Infections (HAIs)
8.2.4. Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG)
8.2.5. Human papillomavirus (HPV)
8.2.6. Tuberculosis
8.2.7. Influenza
8.2.8. COVID-19
8.2.9. Other Infectious Diseases
8.3. Oncology
8.3.1. Breast Cancer
8.3.2. Colorectal Cancer
8.3.3. Lung Cancer
8.3.4. Prostate Cancer
8.3.5. Lymphoma Cancer
8.3.6. Leukemia Cancer
8.3.7. Cervical Cancer
8.3.8. Other Cancer Types
8.4. Genetic Testing
8.5. Neurological Diseases
8.6. Cardiovascular Diseases
8.7. Other Applications
9. Molecular Diagnostics Market, by End User
9.1. Introduction
9.2. Hospitals & Clinics
9.3. Diagnostic Laboratories
9.4. Academic & Research Institutes
9.5. Other End Users
10. Molecular Diagnostics Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. Rest of Asia-Pacific
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Middle East & Africa
11. Competitive Landscape
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2021)
12. Company Profiles
12.1. F. Hoffmann-La Roche Ltd.
12.2. Hologic, Inc.
12.3. QIAGEN N.V.
12.4. Danaher Corporation
12.5. bioMérieux S.A.
12.6. Becton, Dickinson and Company (BD)
12.7. Siemens Healthineers AG
12.8. DiaSorin S.p.A.
12.9. Abbott Laboratories
12.10. Thermo Fisher Scientific Inc.
12.11. Agilent Technologies, Inc.
12.12. Illumina, Inc.
13. Appendix
13.1. Questionnaire
13.2. Available Customization
List of Tables
Table 1 Global Molecular Diagnostics Market: Impact Analysis of Market Drivers (2022–2029)
Table 2 Global Molecular Diagnostics Market: Impact Analysis of Market Restraints (2022–2029)
Table 3 Global Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 4 Global Molecular Diagnostics Reagents & Kits Market Size, by Country/Region, 2020–2029 (USD Million)
Table 5 Global Molecular Diagnostics Instruments/Systems Market Size, by Country/Region, 2020–2029 (USD Million)
Table 6 Global Molecular Diagnostics Software & Services Market Size, by Country/Region, 2020–2029 (USD Million)
Table 7 Global Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 8 Global Molecular Diagnostics for Lab Tests, by Country/Region, 2020–2029 (USD Million)
Table 9 Global Molecular Diagnostics for PoC Tests, by Country/Region, 2020–2029 (USD Million)
Table 10 Global Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 11 Global Molecular Diagnostics for Polymerase Chain Reaction (PCR), by Country/Region, 2020–2029 (USD Million)
Table 12 Global Molecular Diagnostics for In Situ Hybridization (ISH), by Country/Region, 2020–2029 (USD Million)
Table 13 Global Molecular Diagnostics for Isothermal Nucleic Acid Amplification Technology (INAAT), by Country/Region, 2020–2029 (USD Million)
Table 14 Global Molecular Diagnostics for Chips and Microarrays, by Country/Region, 2020–2029 (USD Million)
Table 15 Global Molecular Diagnostics for Mass Spectrometry, by Country/Region, 2020–2029 (USD Million)
Table 16 Global Molecular Diagnostics for Sequencing, by Country/Region, 2020–2029 (USD Million)
Table 17 Global Molecular Diagnostics for Transcription Mediated Amplification (TMA), by Country/Region, 2020–2029 (USD Million)
Table 18 Global Other Technologies Market Size, by Country/Region, 2020–2029 (USD Million)
Table 19 Global Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 20 Global Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 21 Global Molecular Diagnostics Market Size for Infectious Diseases Market Size, by Country/Region, 2020–2029 (USD Million)
Table 22 Global Molecular Diagnostics Market Size for Hepatitis, by Country/Region, 2020–2029 (USD Million)
Table 23 Global Molecular Diagnostics Market Size for HIV, by Country/Region, 2020–2029 (USD Million)
Table 24 Global Molecular Diagnostics Market Size for Healthcare-associated Infections (HAIs), by Country/Region, 2020–2029 (USD Million)
Table 25 Global Molecular Diagnostics Market Size for Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG), by Country/Region, 2020–2029 (USD Million)
Table 26 Global Molecular Diagnostics Market Size for Human papillomavirus (HPV), by Country/Region, 2020–2029 (USD Million)
Table 27 Global Molecular Diagnostics Market Size for Tuberculosis, by Country/Region, 2020–2029 (USD Million)
Table 28 Global Molecular Diagnostics Market Size for Influenza, by Country/Region, 2020–2029 (USD Million)
Table 29 Global Molecular Diagnostics Market Size for COVID-19, by Country/Region, 2020–2029 (USD Million)
Table 30 Global Molecular Diagnostics Market Size for Other Infectious Diseases, by Country/Region, 2020–2029 (USD Million)
Table 31 Global Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 32 Global Molecular Diagnostics Market Size for Oncology, by Country/Region, 2020–2029 (USD Million)
Table 33 Global Molecular Diagnostics Market Size for Breast Cancer, by Country/Region, 2020–2029 (USD Million)
Table 34 Global Molecular Diagnostics Market Size for Colorectal Cancer, by Country/Region, 2020–2029 (USD Million)
Table 35 Global Molecular Diagnostics Market Size for Lung Cancer, by Country/Region, 2020–2029 (USD Million)
Table 36 Global Molecular Diagnostics Market Size for Prostate Cancer, by Country/Region, 2020–2029 (USD Million)
Table 37 Global Molecular Diagnostics Market Size for Lymphoma Cancer, by Country/Region, 2020–2029 (USD Million)
Table 38 Global Molecular Diagnostics Market Size for Leukemia Cancer, by Country/Region, 2020–2029 (USD Million)
Table 39 Global Molecular Diagnostics Market Size for Cervical Cancer, by Country/Region, 2020–2029 (USD Million)
Table 40 Global Molecular Diagnostics Market Size for Other Cancer Types, by Country/Region, 2020–2029 (USD Million)
Table 41 Global Molecular Diagnostics Market Size for Genetic Testing, by Country/Region, 2020–2029 (USD Million)
Table 42 Global Molecular Diagnostics Market Size for Neurological Diseases, by Country/Region, 2020–2029 (USD Million)
Table 43 Global Molecular Diagnostics Market Size for Other Applications, by Country/Region, 2020–2029 (USD Million)
Table 44 Global Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 45 Global Molecular Diagnostics Market Size for Hospitals & Clinics, by Country/Region, 2020–2029 (USD Million)
Table 46 Global Molecular Diagnostics Market Size for Diagnostic Laboratories, by Country/Region, 2020–2029 (USD Million)
Table 47 Global Molecular Diagnostics Market Size for Academic & Research Institutes, by Country/Region, 2020–2029 (USD Million)
Table 48 Global Molecular Diagnostics Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million)
Table 49 Global Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 50 North America: Molecular Diagnostics Market Size, by Country, 2020–2029 (USD Million)
Table 51 North America: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 52 North America: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 53 North America: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 54 North America: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 55 North America: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 56 North America: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 57 North America: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 58 U.S.: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 59 U.S.: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 60 U.S.: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 61 U.S.: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 62 U.S.: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 63 U.S.: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 64 U.S.: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 65 Canada: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 66 Canada: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 67 Canada: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 68 Canada: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 69 Canada: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 70 Canada: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 71 Canada: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 72 Europe: Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 73 Europe: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 74 Europe: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 75 Europe: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 76 Europe: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 77 Europe: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 78 Europe: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 79 Europe: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 80 Germany: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 81 Germany: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 82 Germany: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 83 Germany: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 84 Germany: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 85 Germany: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 86 Germany: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 87 France: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 88 France: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 89 France: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 90 France: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 91 France: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 92 France: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 93 France: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 94 U.K.: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 95 U.K.: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 96 U.K.: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 97 U.K.: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 98 U.K.: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 99 U.K.: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 100 U.K.: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 101 Italy: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 102 Italy: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 103 Italy: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 104 Italy: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 105 Italy: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 106 Italy: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 107 Italy: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 108 Spain: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 109 Spain: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 110 Spain: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 111 Spain: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 112 Spain: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 113 Spain: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 114 Spain: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 115 RoE: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 116 RoE: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 117 RoE: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 118 RoE: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 119 RoE: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 120 RoE: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 121 RoE: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 122 Asia-Pacific: Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 123 Asia-Pacific: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 124 Asia-Pacific: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 125 Asia-Pacific: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 126 Asia-Pacific: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 127 Asia-Pacific: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 128 Asia-Pacific: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 129 Asia-Pacific: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 130 China: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 131 China: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 132 China: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 133 China: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 134 China: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 135 China: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 136 China: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 137 Japan: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 138 Japan: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 139 Japan: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 140 Japan: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 141 Japan: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 142 Japan: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 143 Japan: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 144 India: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 145 India: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 146 India: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 147 India: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 148 India: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 149 India: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 150 India: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 151 Australia: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 152 Australia: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 153 Australia: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 154 Australia: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 155 Australia: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 156 Australia: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 157 Australia: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 158 RoAPAC: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 159 RoAPAC: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 160 RoAPAC: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 161 RoAPAC: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 162 RoAPAC: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 163 RoAPAC: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 164 RoAPAC: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 165 Latin America: Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 166 Latin America: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 167 Latin America: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 168 Latin America: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 169 Latin America: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 170 Latin America: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 171 Latin America: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 172 Latin America: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 173 Brazil: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 174 Brazil: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 175 Brazil: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 176 Brazil: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 177 Brazil: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 178 Brazil: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 179 Brazil: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 180 Mexico: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 181 Mexico: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 182 Mexico: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 183 Mexico: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 184 Mexico: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 185 Mexico: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 186 Mexico: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 187 RoLATAM: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 188 RoLATAM: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 189 RoLATAM: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 190 RoLATAM: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 191 RoLATAM: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 192 RoLATAM: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 193 RoLATAM: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 194 Middle East & Africa: Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 195 Middle East & Africa: Molecular Diagnostics Market Size, by Test Type, 2020–2029 (USD Million)
Table 196 Middle East & Africa: Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 197 Middle East & Africa: Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 198 Middle East & Africa: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million)
Table 199 Middle East & Africa: Molecular Diagnostics Market Size for Oncology, by Type, 2020–2029 (USD Million)
Table 200 Middle East & Africa: Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 201 Recent Developments, by Company, 2020—2022
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Molecular Diagnostic Market Size, by Product, 2022 VS. 2029 (USD Million)
Figure 8 Global Molecular Diagnostic Market Size, by Test Type, 2022 VS. 2029 (USD Million)
Figure 9 Global Molecular Diagnostic Market Size, by Technology, 2022 VS. 2029 (USD Million)
Figure 10 Global Molecular Diagnostic Market Size, by Application, 2022 VS. 2029 (USD Million)
Figure 11 Global Molecular Diagnostic Market Size, by End User, 2022 VS. 2029 (USD Million)
Figure 12 Molecular Diagnostic Market, by Region
Figure 13 Market Dynamics
Figure 14 Global Molecular Diagnostics Market Size, by Product, 2022–2029 (USD Million)
Figure 15 Global Molecular Diagnostics Market Size, by Test Type, 2022–2029 (USD Million)
Figure 16 Global Molecular Diagnostics Market Size, by Technology, 2022–2029 (USD Million)
Figure 17 Global Molecular Diagnostics Market Size, by Application, 2022–2029 (USD Million)
Figure 18 Global Molecular Diagnostics Market Size, by End User, 2022–2029 (USD Million)
Figure 19 Global Molecular Diagnostics Market Size, by Region, 2022–2029 (USD Million)
Figure 20 North America: Molecular Diagnostics Market Snapshot
Figure 21 Europe: Molecular Diagnostics Market Snapshot
Figure 22 Asia-Pacific: Molecular Diagnostics Market Snapshot
Figure 23 Latin America: Molecular Diagnostics Market Snapshot
Figure 24 Key Growth Strategies Adopted by Leading Players, 2020—2022
Figure 25 Molecular Diagnostics Market: Competitive Benchmarking, by Product
Figure 26 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
Figure 27 Hologic, Inc.: Financial Overview (2021)
Figure 28 QIAGEN N.V.: Financial Overview (2021)
Figure 29 Danaher Corporation: Financial Overview (2021)
Figure 30 bioMérieux S.A.: Financial Overview (2021)
Figure 31 Becton, Dickinson and Company: Financial Overview (2021)
Figure 32 Siemens Healthineers AG: Financial Overview (2021)
Figure 33 DiaSorin S.p.A.: Financial Overview (2021)
Figure 34 Abbott Laboratories: Financial Overview (2021)
Figure 35 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 36 Agilent Technologies, Inc.: Financial Overview (2021)
Figure 37 Illumina, Inc.: Financial Overview (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2023
Published Date: Jan-2023
Published Date: Jan-2023
